Search research articles
Contact Us
Filters
Showing results (21-30 of 252) with videos related to
Page
of 26
Sort By:
Trends in Molecular Medicine
|
April 3, 2004
Kaposi's sarcoma as a model for cancer immunotherapy
Justin Stebbing, Mark Bower, Pramod Srivastava
Cancer Treatment Reviews
|
April 3, 2004
The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma
Justin Stebbing, Vanessa Marvin, Mark Bower
Future Oncology (London, England)
|
August 23, 2006
Chemotherapy for advanced cholangiocarcinoma: what is standard treatment?
Danish Mazhar, Justin Stebbing, Mark Bower
Journal of HIV Therapy
|
June 22, 2007
Non-AIDS-defining cancers in people with HIV infection: a sleeping giant?
Thomas Powles, Tim Oliver, Mark Bower
Gender Medicine
|
November 21, 2007
HIV-associated Kaposi sarcoma and gender
Jayson Wang, Justin Stebbing, Mark Bower
Current Opinion in Infectious Diseases
|
December 24, 2005
AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy
Mark Bower, Carlo Palmieri, Tony Dhillon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2006
Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer?
Mark Bower, Danish Mazhar, Justin Stebbing
Expert Review of Anticancer Therapy
|
March 1, 2006
Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals
Danish Mazhar, Justin Stebbing, Mark Bower
AIDS (London, England)
|
July 11, 2003
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma
Simon Portsmouth, Justin Stebbing, Jas Gill, et al.
Current Opinion in Oncology
|
December 25, 2008
Smoke and mirrors: HIV-related lung cancer
Alexandra Bazoes, Mark Bower, Thomas Powles
Page
of 26
Search research articles
Search
Showing results (21-30 of 252) with videos related to
Sort By:
Page
of 26
Trends in Molecular Medicine
|
April 3, 2004
Kaposi's sarcoma as a model for cancer immunotherapy
Justin Stebbing, Mark Bower, Pramod Srivastava
Cancer Treatment Reviews
|
April 3, 2004
The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma
Justin Stebbing, Vanessa Marvin, Mark Bower
Future Oncology (London, England)
|
August 23, 2006
Chemotherapy for advanced cholangiocarcinoma: what is standard treatment?
Danish Mazhar, Justin Stebbing, Mark Bower
Journal of HIV Therapy
|
June 22, 2007
Non-AIDS-defining cancers in people with HIV infection: a sleeping giant?
Thomas Powles, Tim Oliver, Mark Bower
Gender Medicine
|
November 21, 2007
HIV-associated Kaposi sarcoma and gender
Jayson Wang, Justin Stebbing, Mark Bower
Current Opinion in Infectious Diseases
|
December 24, 2005
AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy
Mark Bower, Carlo Palmieri, Tony Dhillon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2006
Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer?
Mark Bower, Danish Mazhar, Justin Stebbing
Expert Review of Anticancer Therapy
|
March 1, 2006
Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals
Danish Mazhar, Justin Stebbing, Mark Bower
AIDS (London, England)
|
July 11, 2003
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma
Simon Portsmouth, Justin Stebbing, Jas Gill, et al.
Current Opinion in Oncology
|
December 25, 2008
Smoke and mirrors: HIV-related lung cancer
Alexandra Bazoes, Mark Bower, Thomas Powles
Page
of 26